MetaCap

Oaktree Acquisition Corp. III Life Sciences Class A (OACC)

NASDAQ: OACCFinanceBlank ChecksUSD

10.71-0.02 (-0.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OACC stock chart

Technical analysis

Key statistics

All statistics
Market cap
$141.93M
52-week range
10.50 – 10.93
Day range
10.71 – 10.71
Volume / Avg
491 / 28.11K
Beta
—

52-week range

$10.50$10.93

OACC stock today

Oaktree Acquisition III Life Sciences (OACC) closed at $10.71 on Nov 20, down 0.19% (-$0.02), versus the S&P 500's 3.70% decline. Trading was light, with 491 shares changing hands, about 2% of the average daily volume. At this level, OACC sits in the middle of its 52-week range of $10.50 to $10.93: 2.0% below the high, set on Oct 14, 2026 and 2.0% above the low.

OACC is up 1.2% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 1.4%. Oaktree Acquisition III Life Sciences trades at 59.5x its trailing twelve-month earnings per share of $0.18.

Summary generated from market data by MetaCap's automated system. Methodology

About Oaktree Acquisition III Life Sciences

Company profile

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

Sector
Finance
Industry
Blank Checks
CEO
Mr. Zaid Pardesi
Headquarters
Los Angeles, CA
IPO year
2024

Financial highlights

Full financials

Net income was $7.3 million.

Oaktree Acquisition III Life Sciences annual revenue, net income and EPS
Fiscal yearFY 2025
Revenue—
Growth—
Net income$7.29M
EPS (diluted)—

Oaktree Acquisition III Life Sciences peers

Finance sector

Indexes, lists and sector

Oaktree Acquisition III Life Sciences stock FAQ

What is Oaktree Acquisition III Life Sciences's stock price today?

OACC last traded at $10.71 as of Nov 20, 4:00 PM EST, down 0.19% on the day. Prices are delayed at least 15 minutes.

What is OACC's P/E ratio?

OACC trades at a trailing P/E ratio of 59.50.

Who is Oaktree Acquisition III Life Sciences's CEO?

Mr. Zaid Pardesi is the chief executive officer of Oaktree Acquisition Corp. III Life Sciences Class A.

What is the OACC 52-week high?

The 52-week high for OACC is $10.93 and the 52-week low is $10.50. The stock is currently 2.0% below its high.

Compare OACC